<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02681029</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-Emb-023</org_study_id>
    <nct_id>NCT02681029</nct_id>
  </id_info>
  <brief_title>The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos</brief_title>
  <official_title>Evaluating the Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos at Royan Institute: A Phase 3, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent improvements in cell culture systems have led to a shift in in vitro fertilization&#xD;
      (IVF) practice from early cleavage stage embryo transfer (ET) to blastocyst transfer.&#xD;
      Blastocyst culture and transfer could theoretically provide better synchronization between&#xD;
      the embryo and the uterine endometrium. The purpose of this study is comparing pregnancy&#xD;
      rates and implantation rate following transfer of thawed cleavage embryos and blastocysts&#xD;
      cultured from thawed cleavage embryos.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposal of this study approved by our institutional review boards and institution's&#xD;
      ethical committee, and all participants will sign a written consent before enter to study.&#xD;
      All patients will be randomly divided into two groups of thawed cleavage embryo transfers and&#xD;
      transfers of blastocysts from thawed cleavage embryos. Embryos will be transferred in hormone&#xD;
      replacement cycles. Preparation of the endometrium will be started in the second day of&#xD;
      menstruation and will be continued according to their transfer type (blastocyst or cleavage).&#xD;
      βhCG will be assessed 14 days after embryo transfer. Treatment cycle outcomes will be&#xD;
      compared between 2 groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">September 27, 2020</completion_date>
  <primary_completion_date type="Actual">July 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy Rate</measure>
    <time_frame>4weeks</time_frame>
    <description>Evaluation of pregnancy rate in women 4 weeks after embryos transfer (ET).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Miscarriage Rate</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation the miscarriage rate in women 14 days after embryo transfer (ET) with BHCG titration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation Rate</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation the implantation rate in women 14 days after embryo transfer (ET) with BHCG titration..</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation the ongoing pregnancy rate in women 14 days after embryo transfer (ET) with BHCG titration..</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Blastocyst transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The infertile women who underwent intra- uterus transferring of blastocyst from thawed cleavage embryo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The infertile women who underwent intra- uterus transferring of thawed cleavage embryo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blastocyte Transferring</intervention_name>
    <description>Intra-uterine transferring of blastocyst from thawed cleavage embryo in infertile women.</description>
    <arm_group_label>Blastocyst transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Embryo Transferring</intervention_name>
    <description>Inta-uterine transferring of thawed cleavage embryo transfer in infertile women.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patients with first type of infertility&#xD;
&#xD;
          -  Age ≤ 37 years&#xD;
&#xD;
          -  Long ovulation induction protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any previous surgery on the uterus and ovaries&#xD;
&#xD;
          -  Uterine factor infertility&#xD;
&#xD;
          -  Sever Male factor infertility (TESE, TESA ،Oligoteratozoospermia)&#xD;
&#xD;
          -  Recurrent abortion&#xD;
&#xD;
          -  The women with poor ovarian reserve&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamid Gourabi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Head of Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tahereh Madani, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Poopak Eftekhari-Yazdi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadia Jahangiri, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://Royaninstitute.org</url>
    <description>Related Info</description>
  </link>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>February 2, 2016</study_first_submitted>
  <study_first_submitted_qc>February 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2016</study_first_posted>
  <last_update_submitted>May 8, 2021</last_update_submitted>
  <last_update_submitted_qc>May 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cleavage stage blastocyst transfer cryopreservation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

